戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 hrombocytopenic by i.p. administration of an antiplatelet antibody.
2 hrombosis and shock observed with activating antiplatelet antibody.
3 d severe thrombocytopenia than nonactivating antiplatelet antibody.
4 plore the consequences in vivo of activating antiplatelet antibodies.
5  thrombocytopenia mediated by drug-dependent antiplatelet antibodies.
6 esponse to cytotoxic anti-red blood cell and antiplatelet antibodies.
7 hrombosis in patients with heparin-dependent antiplatelet: antibodies.
8 0 to 2 g/kg IVIG and then challenged with an antiplatelet antibody (7E3, 8 mg/kg).
9  peripheral platelet destruction mediated by antiplatelet antibodies (Abs) and/or platelet-bound immu
10 whether breast milk of ITP mothers contained antiplatelet antibodies causing persistent thrombocytope
11 th previous work, IVIG was found to increase antiplatelet antibody clearance in a dose-dependent mann
12                                      Without antiplatelet antibodies, CRP was found to be inert towar
13 ction in ITP (ie, IVIG-mediated increases in antiplatelet antibody elimination).
14                            Thus, transfer of antiplatelet antibodies from ITP mothers by breastfeedin
15       Flow cytometry was used to demonstrate antiplatelet antibodies in 80% of first serum samples fr
16 ls into plasma cells and to the secretion of antiplatelet antibodies in ITP patients.
17        The detection of vancomycin-dependent antiplatelet antibodies in patients receiving the antibi
18                                              Antiplatelet antibodies may contribute to the profound t
19                 We found increased levels of antiplatelet antibodies of the immunoglobulin A type in
20                                              Antiplatelet-antibody-producing B cells play a key role
21 ing bone marrow aspiration, Coombs test, and antiplatelet antibody test were negative.
22  immune thrombocytopenia (ITP) commonly have antiplatelet antibodies that cause thrombocytopenia thro
23 choline exposed after oxidation triggered by antiplatelet antibodies, thereby enhancing platelet phag
24                                The use of an antiplatelet antibody to halve platelet counts in tumor-

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。